Considerations for the Reorganization of Cancer Services during the COVID-19 Pandemic, 26 May 2020
MetadataShow full item record
Other Language Versions
Since the onset of the COVID-19 pandemic, health systems around the world have focused on reorganizing healthcare services and prioritizing hospital beds and intensive care units to manage people with COVID-19. This has included the suspension or reduction of elective cancer care and clinical visits for assessment, diagnosis and management, except for high-risk cancer patients. It has been noted that people who have COVID-19 and an underlying condition such as cancer have higher mortality than those without cancer. In addition, people with cancer are more likely to have complications from COVID-19. Despite strategies to maintain health services such as hemodialysis, oncology, chemotherapy, and others, there has been a significant reduction in access to service for patients who were being diagnosed or treated for cancer, due to their high risk. Studies have demonstrated that delays in cancer diagnosis and treatment have an impact on the progression of cancer. This could lead to future peaks in mortality from potentially curable cancers, as a result of not receiving standard treatment. For this reason, cancer services should rapidly manage and avoid any cumulative delays in treatment and prevent an increase in avoidable deaths from cancer.
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Showing items related by title, author, creator and subject.
Mitigating the Indirect Impacts of COVID-19 on Maternal, Newborn, Child and Adolescent, and Ageing Health Services: Lessons Learned from the Experience of Brazil Pan American Health Organization; Family, Health Promotion and Life Course (FPL) (Washington, D.C., PAHO, 2022-10-05)The COVID-19 pandemic disrupted daily lives in several dimensions. One of them was the disruption of health services. During the first two years of the pandemic, the rapid increase in severe cases and hospitalizations ...
Updated Recommendations for Determining the Number of People with HIV Receiving Antiretroviral Therapy, September 2021 Pan American Health Organization (Washington, D.C., PAHO, 2022-01-31)To reach the 95-95-95 targets towards HIV elimination, it is essential to have high quality data to guide programmatic actions in the best possible way. Along these lines, accurate knowledge on the number of people on ...
Guidelines for the Prophylaxis and Management of Patients with Non-severe COVID-19 in Latin America and the Caribbean. Abridged version, third edition Pan American Health Organization; Evidence and Intelligence for Action in Health (EIH) (Washington, D.C., PAHO, 2023-03-24)In this third edition of the abridged version of the Guidelines for the prophylaxis and management of patients with NON-SEVERE COVID-19 in Latin America and the Caribbean, the evidence-based recommendations for the prophylaxis ...